Beijing SL Pharmaceutical Co Ltd (002038) — Free Cash Flow Generation Index
Beijing SL Pharmaceutical Co Ltd (002038) has a Free Cash Flow Generation Index of 0.83x as of September 2025. Free cash flow of CN¥55.21 Million represents 1% of operating cash flow (CN¥66.55 Million). See Beijing SL Pharmaceutical Co Ltd (002038) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Beijing SL Pharmaceutical Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Beijing SL Pharmaceutical Co Ltd across 23 annual periods. Explore cash flow to debt ratio of Beijing SL Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Beijing SL Pharmaceutical Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Beijing SL Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002038 company net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥64.69 Million | CN¥257.66 Million | CN¥192.97 Million | ▲ +146.4% |
| 2024 | -0.54x | CN¥-121.89 Million | CN¥225.49 Million | CN¥347.38 Million | ▼ -202.9% |
| 2023 | 0.53x | CN¥241.84 Million | CN¥460.20 Million | CN¥218.36 Million | ▼ -9.5% |
| 2022 | 0.58x | CN¥226.33 Million | CN¥389.82 Million | CN¥163.49 Million | ▲ +18.5% |
| 2021 | 0.49x | CN¥227.72 Million | CN¥464.63 Million | CN¥236.91 Million | ▲ +27.5% |
| 2020 | 0.38x | CN¥159.89 Million | CN¥415.84 Million | CN¥255.95 Million | ▼ -34.9% |
| 2019 | 0.59x | CN¥393.04 Million | CN¥665.83 Million | CN¥272.78 Million | ▲ +11.1% |
| 2018 | 0.53x | CN¥257.80 Million | CN¥485.17 Million | CN¥227.37 Million | ▲ +33.9% |
| 2017 | 0.40x | CN¥151.08 Million | CN¥380.72 Million | CN¥229.65 Million | ▼ -32.3% |
| 2016 | 0.59x | CN¥232.65 Million | CN¥396.86 Million | CN¥164.21 Million | ▼ -21.1% |
| 2015 | 0.74x | CN¥375.19 Million | CN¥504.87 Million | CN¥129.68 Million | ▲ +10.1% |
| 2014 | 0.68x | CN¥313.99 Million | CN¥465.00 Million | CN¥151.01 Million | ▼ -1.4% |
| 2013 | 0.68x | CN¥237.94 Million | CN¥347.41 Million | CN¥109.48 Million | ▲ +81.1% |
| 2012 | 0.38x | CN¥150.70 Million | CN¥398.60 Million | CN¥247.89 Million | ▼ -44.4% |
| 2011 | 0.68x | CN¥155.54 Million | CN¥228.59 Million | CN¥73.05 Million | ▼ -16.9% |
| 2010 | 0.82x | CN¥195.09 Million | CN¥238.13 Million | CN¥43.04 Million | ▼ -0.7% |
| 2009 | 0.83x | CN¥143.95 Million | CN¥174.41 Million | CN¥30.46 Million | ▼ -6.0% |
| 2008 | 0.88x | CN¥170.71 Million | CN¥194.32 Million | CN¥23.61 Million | ▲ +25.7% |
| 2007 | 0.70x | CN¥61.75 Million | CN¥88.36 Million | CN¥26.61 Million | ▲ +644.0% |
| 2006 | -0.13x | CN¥-7.39 Million | CN¥57.55 Million | CN¥64.95 Million | ▲ +81.9% |
| 2005 | -0.71x | CN¥-33.76 Million | CN¥47.48 Million | CN¥81.24 Million | ▼ -264.3% |
| 2004 | 0.43x | CN¥13.53 Million | CN¥31.26 Million | CN¥17.73 Million | ▼ -6.4% |
| 2003 | 0.46x | CN¥14.12 Million | CN¥30.55 Million | CN¥16.43 Million | — |